Glad to see someone is on board with making replication a top priority! Although the notion that NIH is “scaling down” our work on replication is complete fiction. We are deeply committed to making replication a core part of the biomedical research enterprise. Work is moving forward on many fronts: 🔎 Investing $174M in efforts to test interventions that incentivize replication, support research with built-in replication, and more. 🔎 Created the Linked Discoveries tool in PubMed Central, which connects researchers with related evidence and replication studies. 🔎 Issued highlighted topic encouraging research on rigor, transparency and replicability. 🔎 Creating a new S-index to measure (and incentivize) data sharing among researchers, with other new metrics to come. 🔎 [Coming soon]: a new journal focused on replication work. No amount of money will fix the issues the scientific enterprise faces on this topic. It requires a major cultural change affecting how we conduct, evaluate and reward scientific work. The culture of biomedical science must reward replicable, reproducible research — or else we won’t make much progress improving human health.